Feasibility Assessment of Cardiovascular Endurance Training for the Symptomatic Improvement of Irritable Bowel Syndrome Patients With a Sedentary and Non-active Lifestyle.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversitair Ziekenhuis Brussel

About this trial

This exploratory study's primary objective is the changes of irritable bowel syndrome (IBS) symptom severity by cardiovascular endurance training (CET) in relation to the baseline sedentary or non-active lifestyle. Secondary endpoints focus on the mechanisms associated with these changes.

These mechanisms relate to dietary adaptations, changes in anxiety, depressive comorbidity, somatisation, alterations in the gut microbiome or metabolome, body composition and measures of cardiovascular fitness. Virtually all IBS guidelines mention lifestyle modifications as a management option.

Research on the role of physical activity remains underassessed as compared to the other interventions. Therefore, an exploratory proof-of-concept study will investigate the influence of regular physical exercise on symptoms in a small group of IBS patients. This study will gather data on putative underlying mechanisms related to dietary factors, faecal microbiome and metabolome, mental well-being, body composition and cardiovascular fitness.

Eligibility criteria

Qualifiers

Patients aged 18 - 60 years;

Fulfilling the ROME IV criteria for Irritable bowel syndrome (IBS);

Moderate symptom severity as defined by a IBS-Symptom Severity Scale > 175;

Sedentary lifestyle defined as SIT-Q-7D > 8h/day;

Disqualifiers

Cardiorespiratory disorder hampering participation in a program of physical exercise as evidenced by the sport + keuringsartsen (SKA) questionnaire.

Clinical suspicion of an organic disorder different from IBS (patients can be included when this disorder had been excluded);

Known inflammatory bowel disorder;

Known intestinal motility disorder;

Trial design

Treatments tested in this trial

  • Cardiovascular endurance training

Treatment groups

30 Participants
are divided into 1 treatment group